15.09.2014 - ​Danaher will buy Swiss company

American Danaher Corporation today announced its intention to buy the manufacturer of dental implant company Nobel Biocare Holdings. The transaction value is approximately USD 2.1 billion. Acquisition will allow Danaher to strengthen its position on the market for health care. The deal should be completed in late 2014 or early 2015. In 2103 Nobel Biocare Holdings received approximately 57.2 million dollars in profits. Considering stability of the company's business, we expect growth of quotations of Danaher in the next six months by 7-10%.

RISK WARNING: Trading of complex financial products, such as Stocks, Futures, Foreign Exchange ("Forex"), Contracts for Difference ("CFDs"), Indices, Options, or other financial derivatives, on "margin" carries a high level of risk, and may not be suitable for all investors. The possibility exists that you could sustain a loss of some or all of your initial investment and, therefore, you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading these markets, and seek advice from an independent financial advisor if you have any questions or doubts. Please carefully read our full "Risk Disclosure" and "Risk Disclosures for Financial Instruments & Investment Services". FXFINPRO Capital is the trading name of PFX Financial Professionals Limited, a limited liability company formed under the laws of Cyprus, registered with the Registrar of Companies in Nicosia, Cyprus, under nr. HE 237840 and regulated by the Cyprus Securities and Exchange Commission with license number 193/13.